dc.creator | Folschweiller, Nicolas | |
dc.creator | Teixeira, Julio | |
dc.creator | Joshi, Smita | |
dc.creator | Goldani, Luciano Z. | |
dc.creator | Supparatpinyo, Khuanchai | |
dc.creator | Basu, Partha | |
dc.creator | Chotpitayasunondh, Tawee | |
dc.creator | Chetchotisakd, Ploenchan | |
dc.creator | Ruxrungtham, Kiat | |
dc.creator | Roteli-Martins, Cecilia | |
dc.creator | Grinsztejn, Beatriz | |
dc.creator | Quintana, Silvana Maria | |
dc.creator | Kumarasamy, Nagalingeswaran | |
dc.creator | Poongulali, Selvamuthu | |
dc.creator | Kulkarni, Vinay | |
dc.creator | Lin, Lan | |
dc.creator | Datta, Sanjoy K. | |
dc.creator | Descamps, Dominique | |
dc.creator | Dodet, Monique | |
dc.creator | Dubin, Gary | |
dc.creator | Friel, Damien | |
dc.creator | Hezareh, Marjan | |
dc.creator | Karkada, Naveen | |
dc.creator | Meric Camilleri, Dorothee | |
dc.creator | Poncelet, Sylviane | |
dc.creator | Salaun, Bruno | |
dc.creator | Tavares-da-Silva, Fernanda | |
dc.creator | Thomas-Jooris, Florence | |
dc.creator | Struyf, Frank | |
dc.date.accessioned | 2020-07-27T18:42:41Z | |
dc.date.accessioned | 2023-09-05T12:05:03Z | |
dc.date.available | 2020-07-27T18:42:41Z | |
dc.date.available | 2023-09-05T12:05:03Z | |
dc.date.created | 2020-07-27T18:42:41Z | |
dc.date.issued | 2020 | |
dc.identifier | FOLSCHWEILLER, Nicolas et al. Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study. EClinicalMedicine, v. 23, n. 100353, p. 1-16, 2020. | |
dc.identifier | 2589-5370 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/42413 | |
dc.identifier | 10.1016/j.eclinm.2020.100353 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8648995 | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.rights | restricted access | |
dc.title | Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study | |
dc.type | Article | |